Edge Asset Management’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q2
Sell
-118,344
Closed -$6.76M 268
2016
Q1
$6.76M Sell
118,344
-121,910
-51% -$6.79M 0.06% 218
2015
Q4
$14.2M Sell
240,254
-11,438
-5% -$659K 0.14% 186
2015
Q3
$13.7M Sell
251,692
-339,529
-57% -$22.1M 0.14% 180
2015
Q2
$39.7M Sell
591,221
-1,065,594
-64% -$69.6M 0.36% 83
2015
Q1
$97M Sell
1,656,815
-102,444
-6% -$6.19M 0.84% 32
2014
Q4
$115M Sell
1,759,259
-142,411
-7% -$8.98M 1.11% 21
2014
Q3
$110M Buy
1,901,670
+13,678
+0.7% +$759K 1.1% 24
2014
Q2
$107M Buy
1,887,992
+28,810
+2% +$1.51M 1.07% 24
2014
Q1
$95.6M Buy
1,859,182
+39,226
+2% +$1.98M 1.01% 28
2013
Q4
$96.1M Sell
1,819,956
-25,436
-1% -$1.25M 1.05% 25
2013
Q3
$82.5M Buy
1,845,392
+14,644
+0.8% +$649K 0.99% 27
2013
Q2
$75.7M Buy
+1,830,748
New +$80.1M 0.95% 33

Other funds holding ABBV

Edge Asset Management's ABBV Position: Q2 2016 in Review

Edge Asset Management sold out of AbbVie (ABBV) in Q2 2016, closing a stake of 118,344 shares — an estimated $6.76M sold.

Edge Asset Management first reported a position in ABBV in Q2 2013 and held it in 12 quarters. The position peaked at $115M in Q4 2014. 1,636 funds tracked by Wall St. Rank hold ABBV as of Q2 2016.

  • Edge Asset Management reported no remaining AbbVie position as of Q2 2016 after selling out during the quarter.
  • Edge Asset Management sold 118,344 AbbVie shares in Q2 2016, an estimated $6.76M.
  • Edge Asset Management first reported a position in AbbVie in Q2 2013 and held it in 12 quarters.
  • Edge Asset Management's AbbVie position peaked at $115M in Q4 2014.
  • 1,636 funds tracked by Wall St. Rank held AbbVie as of Q2 2016.

Based on Edge Asset Management's 13F filing for Q2 2016, filed 9 Aug 2016.